Not only did India fail to place firm orders with the two companies well in advance, but also it did not provide the companies any funding till a month ago to expand the manufacturing capacities. What it has instead done is to appropriate for its use the vaccine doses which were already paid for by other entities and were meant for other countries under COVAX facility and bilateral agreements. (Read More)
Be the first to comment